Implications of CD39 in immune-related diseases

Area of Science:

• Immunology
• Biochemistry
• Molecular Biology

Background:

• Extracellular adenosine triphosphate (eATP) promotes inflammation by recruiting immune cells.
• CD39 and CD73 enzymes sequentially metabolize eATP to adenosine, an immunosuppressive molecule.
• CD39 acts as a critical regulator, modulating the immune response from pro-inflammatory to anti-inflammatory states.

Purpose of the Study:

• To review the current understanding of CD39's role in immunity.
• To comprehensively illustrate the diverse functions of CD39 in various pathological conditions.

Main Methods:

• Literature review of studies on CD39 function in immunity and disease.
• Analysis of the enzymatic cascade involving CD39 and CD73.
• Examination of CD39 expression in different immune cells and its regulation.

Main Results:

• CD39 is a rate-limiting enzyme in the eATP to adenosine pathway.
• CD39 expression is found on various immune cells and influenced by multiple factors.
• CD39 is implicated in the pathophysiology of inflammatory bowel disease, sepsis, multiple sclerosis, and other disorders.

Conclusions:

• CD39 plays a pivotal role as an immunological switch.
• Understanding CD39 function is crucial for developing therapeutic strategies for inflammatory and autoimmune diseases.
• Further research into CD39's diverse roles in pathology is warranted.